This study reviews developments in experimental studies of photo-induced cooperative phenomena (photo-induced phase transition, PIPT), which involve ultrafast dynamical changes in electronic, spin, and lattice structures. The growth in PIPT research has been driven by deep collaboration among quantum beam, materials, and theoretical sciences. In the early stages of PIPT research, it was thought that the dynamic PIPT process is dominated by energy relaxation from the photoexcited state, a process classified as classical and non-coherent. Using ultrashort-pulse quantum beam technologies, a new ordered phase, the “hidden state”, unique to the photoexcited state, has been observed. In addition, modern laser technology has enabled control over the initial processes of PIPT, especially the formation of hidden states, through coherent coupling between a photon’s electromagnetic field and the materials’ electronic states. This review demonstrates that the PIPT control method has been extended from classical (non-coherent) to coherent processes (a class of quantum processes) through experimental results in collaboration with theoretical science.

Gene expression is determined by the right region and at the right time to shape a cellular function. To understand the landscape of gene expression, large-scale transcriptomic analyses for transcription start sites (where to start) have been employed. However, transcription termination sites (where to stop) and the regulatory mechanisms involved remain largely unclear. Recent studies with state-of-the-art technologies have revealed that RNA polymerase II (Pol II) termination sites are not exact gene ends, but rather within broad downstream-of-gene (DoG) regions. Restriction of DoG transcription contributes to efficient mRNA synthesis, whereas excessive or persistent DoG transcription caused by transcription termination defects blocks DNA replication and produces immunogenic nucleic acids. This review summarizes the latest findings on molecular mechanisms and biological impacts of Pol II transcription termination, and methodologies to investigate them. Finally, we discuss a potential application of Pol II transcription termination regulation for future research directions.

Systemic therapy for biliary tract cancer (BTC) has evolved substantially over the past two decades. Gemcitabine plus cisplatin was established as the global standard first-line regimen, followed by further optimization through alternative doublets, intensified triplet chemotherapy, and the recent introduction of immune checkpoint inhibitor–based combinations. In Japan, pivotal clinical trials have played a valuable role in refining treatment strategies, including the establishment of gemcitabine plus S-1, gemcitabine, cisplatin, plus S-1, and adjuvant S-1 after curative resection. Beyond cytotoxic chemotherapy, molecular targeted therapy and tumor-agnostic approaches have expanded treatment options for selected patients in the second-line and later-line settings. Actionable alterations such as FGFR2 fusions, IDH1 mutations, HER2 amplification, microsatellite instability–high status, and other rare genomic events enable precision medicine approaches with meaningful clinical benefit. Despite these advances, prognosis remains poor for many patients with BTC. Ongoing efforts to optimize treatment sequencing, refine perioperative strategies, and integrate comprehensive molecular profiling are expected to further improve outcomes. Continued generation of high-quality clinical evidence and international collaboration will be essential to advance the management of BTC.
Depression remains a global mental health challenge, with current treatments often limited by therapeutic instability, side effects, and patient adherence. This study investigated Exocarpium Citri Grandis essential oil (ECG oil) as a natural antidepressant. Extraction was optimized using Plackett-Burman Design-Response Surface Methodology (PBD-RSM), achieving a 15.224% yield. Gas chromatography-mass spectrometry (GC-MS) analysis identified D-limonene, α/β-pinene, and γ-terpinene as major active components. In vivo, both oral and nebulized ECG oil significantly alleviated depressive-like behaviors in a zebrafish larval model and chronic unpredictable mild stress (CUMS) mice (evidenced by tail suspension, open field, forced swim, and sucrose preference tests). Biochemically, ECG oil enhanced neurotransmitter activity and reduced monoamine oxidase A (MAOA) levels. Furthermore, network pharmacology coupled with molecular docking and experimental validation (qRT-PCR and Western blot) revealed that ECG oil exerts its efficacy by modulating key targets, including OXT, ESR1, PTGS2, and LEP. Conclusively, ECG oil represents a promising natural therapeutic for depression by regulating neurotransmitter and neuroinflammatory pathways.

This study presents a topology optimization framework for synthesizing planar link mechanisms involving overlapping links. Although topology optimization has been widely applied to compliant mechanisms, its application to link mechanisms remains limited. To address this gap, we introduce a multilayer elasticity model in which two layers are connected by springs, enabling the simultaneous optimization of link and joint placements and link structures. The optimization problem is formulated to generate the target path on the end effector, while accounting for the degrees of freedom required for proper mechanical function. Numerical examples demonstrate that the proposed method successfully generates functional link mechanisms by integrating both layout and structural design. This study contributes to the advancement of topology optimization methods for mechanism design by establishing a framework capable of synthesizing planar link mechanisms with overlapping configurations.
